Miraca Research News: Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

Pathologists at Miraca Life Sciences contributed significantly in the development of a new product from Philips, the IntelliSite Pathology Solution. As one of four clinical study sites, Miraca Life Sciences participated in “one of the largest studies ever conducted to directly compare the use of digital pathology to optical microscopes.” At Miraca, participation in the Philips study was a project of Miraca Research & Development Services.

As stated in its recent announcement, Philips “has received regulatory clearance (via De Novo classification) from the U.S. Food and Drug Administration (FDA) to market its IntelliSite Pathology Solution, a comprehensive digital pathology system.”

The announcement specifies: “Sixteen pathologists at four clinical study sites – Cleveland Clinic, University of Virginia, Miraca Life Sciences and Advanced Pathology Associates – conducted approximately 16,000 reads across 2,000 cases.”

 

 

Dermatology


See why Miraca Life Sciences' dermatopathology service is growing with consultations on biopsies from over 275,000 patients annually.

learn more

Gastroenterology


Explore why Miraca Life Sciences is the largest outpatient gastrointestinal pathology facility in the nation.

learn more

Hematology


Learn how Miraca Life Sciences delivers the highest quality expertise in blood and bone marrow diagnostics.

learn more

Urology


Miraca Life Sciences Urologic Pathology Services

Discover how Miraca Life Sciences' urologic pathology experts focus on service and diagnostic excellence.

learn more